according to their prospectus
Osteopore currently generates revenue in Singapore (6%), Malaysia (2%), South Korea (52%), Vietnam (33%) and in other nations (7%)
They focused on China market late 2019.
Given the virus scare, quarantine, and market stress, SP will probably go lower. 52% of the business is south korea which is badly affected by the virus scare. Even home base Singapore is in code orange. I don't think we've bottomed out yet. Eyeing on a better entry point... I like the business idea. looks like a good spec stock
Ann: Appendix 4E Preliminary Final Report, page-2
Add OSX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.030(9.09%) |
Mkt cap ! $3.099M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.0¢ | 30.0¢ | $93.48K | 307.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1874 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 6102 | 1 |
View Market Depth
| Last trade - 15.53pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
32.0¢ |
Change
-0.030 ( 4.48 %) |
||||
| Open | High | Low | Volume | ||
| 32.0¢ | 33.5¢ | 32.0¢ | 20245 | ||
| Last updated 12.10pm 02/05/2024 ? | |||||
| OSX (ASX) Chart |